Company: COOT
Filing Date: 2025-12-22
Form Type: F-1/A
Source: 0001493152-25-028698
Chunk: 16

Company: Australian Oilseeds Holdings Ltd
Filing Date: 2025-12-22
Form: F-1/A
Chunk 16
---
 in order to remain listed on its exchange. If, for any reason, we should fail to maintain compliance with these listing standards and Nasdaq should delist our securities from trading on its exchange and we are unable to obtain listing on another national securities exchange, a reduction in some or all of the following may occur, each of which could have a material adverse effect on our shareholders:

| ● | the                                                                                                
 liquidity of our Ordinary Shares;                                                                  |
| ● | the                                                                                                
 market price of our Ordinary Shares;                                                               |
| ● | our                                                                                                
 ability to obtain financing for the continuation of our operations;                                |
| ● | the                                                                                                
 number of institutional and general investors that will consider investing in our Ordinary Shares; |
| ● | the                                                                                                
 number of investors in general that will consider investing in our Ordinary Shares;                |
| ● | the                                                                                                
 number of market makers in our Ordinary Shares;                                                    |
| ● | the                                                                                                
 availability of information concerning the trading prices and volume of our Ordinary Shares; and   |
| ● | the                                                                                                
 number of broker-dealers willing to execute trades in our Ordinary Shares.                         |

Our principal shareholders will continue to have significant influence over the election of our board of directors and approval of any significant corporate actions, including any sale of the Company.

Our founders, executive officers, directors, and other principal shareholders, in the aggregate, beneficially own a majority of our outstanding shares. These shareholders currently have, and likely will continue to have, significant influence with respect to the election of our board of directors and approval or disapproval of all significant corporate actions. The concentrated voting power of these shareholders could have the effect of delaying or preventing an acquisition of the Company or another significant corporate transaction.

We could be subject to securities class action litigation.

In the past, securities class action litigation has often been brought against companies following a decline in the market price of their securities. In 2020, 22% of securities class action litigation filings were against defendants in the health technology and services sector, which accounted for 22% of new filings. If we face such litigation, it could result in substantial costs and a diversion of management’s attention and resources, which could harm our business.

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the market price for the shares and trading volume could decline.

The trading market for our Ordinary Shares will depend in part on the research and reports that securities or industry analysts publish about us or our business. If research analysts do not